Roivant Sciences Ltd (ROIV)

Pretax margin

		Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings before tax but after interest (EBT)	US$ in thousands	4,371,150	-1,003,840	-844,893
Revenue	US$ in thousands	90,017	33,312	48,245
Pretax margin		4,855.92%	-3,013.45%	-1,751.26%

March 31, 2024 calculation

Pretax margin = EBT ÷ Revenue
= $4,371,150K ÷ $90,017K
= 4,855.92%

The pretax margin of Roivant Sciences Ltd has shown significant fluctuations over the past three years. In the fiscal year ending March 31, 2024, the company achieved an exceptionally high pretax margin of 4,855.92%. This substantial margin indicates that the company generated a significant amount of profit before accounting for taxes relative to its revenue during that period.

Conversely, in the fiscal year ending March 31, 2023, Roivant Sciences Ltd reported a negative pretax margin of -3,013.45%. This negative margin suggests that the company incurred losses before tax deductions, leading to a financial shortfall during that year.

Similarly, in the fiscal year ending March 31, 2022, the company's pretax margin was also negative at -1,751.26%. This implies that Roivant Sciences Ltd experienced another year of losses before factoring in tax expenses.

Overall, the wide fluctuations in the pretax margin of Roivant Sciences Ltd highlight the volatility and variability in the company's profitability performance over the past three years. Investors and stakeholders may want to further investigate the factors influencing these drastic changes in the company's financial performance.